Drug
Intravitreal Ranibizumab
Intravitreal Ranibizumab: highest development phase Phase 3, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Intravitreal ranibizumab NCT02914626 | Phase 3 | Glaucoma, Neovascular |
Latest
No recent events.
Follow Intravitreal Ranibizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.